Ambrx Biopharma Announces Preclinical Data from Studies in Kidney,…
Ambrx Biopharma Inc AMAM announced new preclinical data from studies ARX517 and ARX305 at the 2023 American Association for Cancer Research (AACR) Annual Meeting.
Home » Biopharma
Ambrx Biopharma Inc AMAM announced new preclinical data from studies ARX517 and ARX305 at the 2023 American Association for Cancer Research (AACR) Annual Meeting.
Management will hold one-on-one meetings with institutional investors and analysts The company recently signed an exclusive option agreement with the Applied Biomedical Science Institute (ABSI)
US stocks traded lower in mid-trade, with the Nasdaq Composite shedding more than 100 points on Thursday. The Dow fell 1.21% to 32,866.56, while the
The company is increasingly concentrating on its core business Christiane Bardroff takes over the global management clinical and commercial manufacturing, engineering and technology operations, and
NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) — Scopus BioPharma Inc. (Nasdaq: “SCPS”)a biopharmaceutical company developing transformative therapeutics for serious diseases with significant unmet medical
Sumitovant Biopharma acquires all outstanding shares of Myovant for $27 per share in cash The combination provides expertise and resources to address unmet patient needs
Ambrx Biopharma Inc AMAM will prioritize ARX517 as the company’s new lead asset. The Company believes that ARX517 has the potential to be the first
SHANGHAI, October 11, 2022 /PRNewswire/ — WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global contract research, development and manufacturing company (CRDMO), and Toregem BioPharma, a
NOVATO, Calif. and MOUNTAIN VIEW, Calif. and LONDON, Sept. 09, 2022 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. RARE(“Ultragenyx”), a biopharmaceutical company focused on the development
INDIANAPOLIS, Sept. 04, 2022 (GLOBE NEWSWIRE) — POINT Biopharma Global Inc. PNT (the “Company” or “POINT”), a company accelerating the discovery, development and global access
As remote work becomes a permanent fixture of American employment, a new national study from John Foy & Associates uncovers the rising dangers hiding behind
A groundbreaking new analysis from High Rise Financial highlights a severe and escalating crisis inside U.S. nursing homes, where tens of thousands of elderly residents
Under Florida’s no-fault system, your PIP pays medical bills (typically 80%) and lost wages (about 60%) after a crash, regardless of fault, but prompt action is crucial. Get treatment within
injuredly News Provide the latest news. All News World News, Business News, Health Care, Life Style. All News Around the World Update On This Website.